European Medicines Agency proposes easier access to overdose antidote

Published 2026-10-22

The European Medicines Agency (EMA) has announced an important decision aimed at saving lives in emergency situations. Experts are proposing that the drug "naloxone," which is used as an antidote for opioid overdoses, be sold in pharmacies without the need for a prescription.

Naloxone in the form of a nasal spray is an extremely effective tool that can quickly stop the effects of dangerous substances in the body. Until now, in many European countries, including Bulgaria, access to this medication was restricted and required a doctor's prescription, which hindered reaction times in critical situations.

According to health experts, removing administrative barriers will allow the families of people at risk to have the drug at home. This is an important step toward reducing deaths caused by the accidental or intentional use of strong painkillers and other opioid substances.

National health authorities in each European Union member state are expected to discuss how to implement these recommendations in practice. If the change is adopted in Bulgaria, it will make it easier for pharmacies to provide emergency assistance to the public.

This initiative is part of the European Union's broader strategy to improve public health and safety. The goal is for life-saving medicines to be as accessible as possible to people when every second counts.

Sources: БНТ Новини

More Bulgaria news

All Bulgaria news · News by country